Ad is loading...
RYVLX
Price
$571.07
Change
+$4.10 (+0.72%)
Updated
Nov 21 closing price
SMPSX
Price
$33.96
Change
+$0.43 (+1.28%)
Updated
Nov 21 closing price
Ad is loading...

RYVLX vs SMPSX

Header iconRYVLX vs SMPSX Comparison
Open Charts RYVLX vs SMPSXBanner chart's image
Rydex NASDAQ-100® 2x Strategy A
Price$571.07
Change+$4.10 (+0.72%)
VolumeN/A
CapitalizationN/A
ProFunds Semiconductor UltraSector Svc
Price$33.96
Change+$0.43 (+1.28%)
VolumeN/A
CapitalizationN/A
RYVLX vs SMPSX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RYVLX vs. SMPSX commentary
Nov 22, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RYVLX is a StrongBuy and SMPSX is a Sell.

FUNDAMENTALS
Fundamentals
RYVLX has more cash in the bank: 1.38B vs. SMPSX (409M). RYVLX (0.00) and SMPSX (0.00) have matching dividends . RYVLX was incepted earlier than SMPSX: RYVLX (20 years) vs SMPSX (24 years). RYVLX is a more actively managed with annual turnover of: 461.00 vs. SMPSX (72.00). RYVLX has a lower initial minimum investment than SMPSX: RYVLX (2500) vs SMPSX (15000). SMPSX annual gain was more profitable for investors over the last year : 136.33 vs. RYVLX (53.22). SMPSX return over 5 years is better than : 598.77 vs. RYVLX (212.88).
RYVLXSMPSXRYVLX / SMPSX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence20 years24 years-
Gain YTD39.619109.09736%
Front LoadN/AN/A-
Min. Initial Investment25001500017%
Min. Initial Investment IRAN/AN/A-
Net Assets1.38B409M338%
Annual Yield % from dividends0.000.00-
Returns for 1 year53.22136.3339%
Returns for 3 years10.72124.909%
Returns for 5 years212.88598.7736%
Returns for 10 years655.52968.7668%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PK14.680.48
+3.38%
Park Hotels & Resorts
VITL31.030.90
+2.99%
Vital Farms
PTC192.754.25
+2.25%
PTC
ZNTL3.180.05
+1.60%
Zentalis Pharmaceuticals
BOLT0.57N/A
-0.56%
Bolt Biotherapeutics